# Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

> **NCT00939965** · NA · UNKNOWN · sponsor: **Children's Cancer and Leukaemia Group** · enrollment: 75 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** isotretinoin
- **GENETIC:** DNA analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00939965
- **Lead sponsor:** Children's Cancer and Leukaemia Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939965, "Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00939965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*